Novartis has transformed its Global Health & Corporate Responsibility (GH&CR) organization. The change consolidates and streamlines expertise and resources to achieve a stronger focus on the areas where the company can have the greatest impact.
“This transformation is yet another demonstration of our unwavering commitment to place global health and corporate responsibility at the core of our business strategy,” said Patrice Matchaba, Group Head, Global Health & Corporate Responsibility.
The new GH&CR organization will oversee end-to-end execution of the company’s global health priorities, from discovery through development to implementation.
